Compare VYNE & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYNE | SNAL |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United States |
| Employees | N/A | 166 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3M | 27.3M |
| IPO Year | 2017 | 2022 |
| Metric | VYNE | SNAL |
|---|---|---|
| Price | $0.64 | $0.62 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 92.5K | ★ 34.3M |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.33 | ★ 120.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $81,225,622.00 |
| Revenue This Year | N/A | $15.53 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.29 | $0.34 |
| 52 Week High | $1.96 | $2.16 |
| Indicator | VYNE | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 48.08 |
| Support Level | $0.56 | $0.53 |
| Resistance Level | $0.75 | $0.89 |
| Average True Range (ATR) | 0.02 | 0.19 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 85.05 | 3.04 |
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.